Table 32—

Recommendations for pulmonary hypertension(PH) due to lung diseases

StatementClass#Level
Echocardiography is recommended as a screening tool for the assessment of PH due to lung diseasesIC
RHC is recommended for a definite diagnosis of PH due to lung diseasesIC
The optimal treatment of the underlying lung disease including long-term O2 therapy in patients with chronic hypoxaemia is recommended in patients with PH due to lung diseasesIC
Patients with “out of proportion” PH due to lung diseases should be enrolled in RCTs targeting PAH-specific drugsIIaC
The use of PAH-specific drug therapy is not recommended in patients with PH due to lung diseasesIIIC
  • RHC: right heart catheterisation; RCT: randomised controlled trial; PAH: pulmonary arterial hypertension. #: class of recommendation; : level of evidence.